Exclusive Enteral Nutrition for Remissionof Crohn's Diseases After Surgery
1 other identifier
interventional
84
1 country
1
Brief Summary
For patients with Crohn's diseases undergoing surgery,whether postoperative exclusive enteral nutrition(EEN) could delay the endoscopic relapse needs exploration.The trial will investigate the efficacy of postoperative EEN for maintaining disease remission.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2020
CompletedFirst Submitted
Initial submission to the registry
January 26, 2022
CompletedFirst Posted
Study publicly available on registry
January 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2023
CompletedOctober 17, 2023
October 1, 2023
7 months
January 26, 2022
October 16, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
postoperative endoscopic recurrence
over i2b of rutgeerts score
1 YEAR
Study Arms (2)
3 months exclusive enteral nutrition after surgery
EXPERIMENTAL3 months exclusive enteral nutrition after surgery
less than 1 months exclusive enteral nutrition after surgery
EXPERIMENTALless than 1 months exclusive enteral nutrition after surgery
Interventions
patients underwent intestinal resection and anastomosis in this arm will given over 3 months exclusive enteral nutrition,and free diet after 3 months.
Eligibility Criteria
You may qualify if:
- \- CD patients who undergoing bowel resection with anastomosis
You may not qualify if:
- patients who received stoma creation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
General Surgery Institute,Jinling Hospital,Nanjing,Jiangsu,China
Nanjing, Jiangsu, 210000, China
Related Publications (1)
Duan M, Lu M, Diao Y, Cao L, Wu Q, Liu Y, Gong J, Zhu W, Li Y. Azathioprine Plus Exclusive Enteral Nutrition Versus Azathioprine Monotherapy for the Prevention of Postoperative Recurrence in Patients with Crohn's Disease: An Open-Label, Single-Centre, Randomized Controlled Trial. J Crohns Colitis. 2024 Aug 6;18(7):1113-1121. doi: 10.1093/ecco-jcc/jjae015.
PMID: 38253914DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Jinling Hospital, China
Study Record Dates
First Submitted
January 26, 2022
First Posted
January 28, 2022
Study Start
January 1, 2020
Primary Completion
July 31, 2020
Study Completion
July 31, 2023
Last Updated
October 17, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share